RUSH (evaluating the efficacy of rosuvastatin for Korean dyslipidemia patients with hypertension in real world practice).
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2010
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms RUSH
- Sponsors AstraZeneca
- 14 Oct 2008 Planned end date changed to 1 Nov 2007 as reported by ClinicalTrials.gov.
- 14 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2007 New trial record.